Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer. FE [Internet]. 2020 Feb. 6 [cited 2025 Oct. 29];21(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1450